Silencing of procaspase-3 and Bcl-2 expression by (chondroitin sulfate)-PAMAM-miR-34a complexes led to an increase in the apoptotic fraction of cancer cells (22% vs. 6% in controls). Here, BCL2 is linked to cancer.